Alexza Pharma (ALXA) Tops Q3 EPS by 7c

November 5, 2015 5:35 PM EST

Alexza Pharma (NASDAQ: ALXA) reported Q3 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings